{
    "nct_id": "NCT03186118",
    "official_title": "Pediatric and Young Adult Leukemia Adoptive Therapy (PLAT)-03: A Pilot Feasibility and Safety Study of CD19t T-Antigen Presenting Cells (T-APCs) Following CAR T Cell Immunotherapy for CD19+ Leukemia",
    "inclusion_criteria": "* Diagnosis of recurrent or refractory CD19+ leukemia\n* Adequate performance status\n* Able to tolerate apheresis, including placement of temporary apheresis line if required\n* Adequate renal, liver, cardiac, and respiratory function\n* Adequate absolute lymphocyte count\n* HIV negative; Hepatitis B and C negative within 3 months prior to enrollment.\nHealthy volunteers allowed\nMust have minimum age of 1 Year\nMust have maximum age of 30 Years",
    "exclusion_criteria": "* Evidence of active clinically significant CNS dysfunction\n* Evidence of active malignancy other than CD19+ malignancy\n* Evidence of active GVHD, or on immunosuppressive GVHD therapy within 4 weeks prior to enrollment",
    "miscellaneous_criteria": ""
}